•Although physiological evidence suggests an inverse relationship between GLP-1 agonism and sexual desire, we posit that this relationship is difficult to observe in clinical practice due to the competing factors influencing sexual desire in patients undergoing obesity treatment with GLP-1 agonists. This evidence concerns the gene GLP1R and obesity disorder.